Mativ's Q3 Loss Narrows, But Goodwill Impairment Hits YTD Hard

Ticker: MATV · Form: 10-Q · Filed: Nov 6, 2025 · CIK: 1000623

Sentiment: bearish

Topics: Goodwill Impairment, Net Loss, Specialty Materials, Financial Performance, Asset Valuation, SEC Filing, 10-Q

TL;DR

**Mativ's massive goodwill write-down makes it a hard pass for now, despite a slightly better quarter.**

AI Summary

Mativ Holdings, Inc. reported a net loss of $3.2 million for the three months ended September 30, 2025, a significant improvement from the $20.8 million net loss in the same period of 2024. However, for the nine months ended September 30, 2025, the company posted a substantial net loss of $438.2 million, a sharp increase from the $50.2 million net loss in the prior year, primarily driven by a $411.9 million goodwill impairment expense. Net sales increased slightly to $513.7 million for the three-month period in 2025, up from $498.5 million in 2024, and to $1,523.9 million for the nine-month period, compared to $1,522.5 million in 2024. Operating profit for the quarter improved to $16.0 million from $7.0 million year-over-year, but the nine-month operating loss was $394.5 million due to the goodwill impairment. Cash provided by operations for the nine months increased to $114.5 million in 2025 from $70.7 million in 2024. The company's total assets decreased from $2,447.9 million at December 31, 2024, to $2,001.5 million at September 30, 2025, largely due to the reduction in goodwill from $465.6 million to $57.3 million.

Why It Matters

Mativ's significant goodwill impairment of $411.9 million for the nine months ended September 30, 2025, signals potential overvaluation of past acquisitions, which could erode investor confidence and impact future capital allocation. While the quarterly net loss improved, the substantial year-to-date loss raises concerns about the company's long-term profitability and competitive positioning in the specialty materials market. Employees might face restructuring or strategic shifts as the company addresses its financial performance, and customers could see changes in product offerings or pricing. This impairment could also affect Mativ's ability to compete effectively against rivals like Avery Dennison or 3M, who operate in similar segments, by limiting investment in innovation or market expansion.

Risk Assessment

Risk Level: high — The company reported a goodwill impairment expense of $411.9 million for the nine months ended September 30, 2025, which is a significant portion of its total assets ($2,001.5 million). This impairment led to a net loss of $438.2 million for the nine-month period, indicating substantial challenges in asset valuation and potential future profitability concerns.

Analyst Insight

Investors should exercise extreme caution and thoroughly review the underlying causes of the $411.9 million goodwill impairment. Consider holding off on new investments until Mativ demonstrates a clear path to sustained profitability and asset value recovery, as the significant write-down suggests fundamental issues.

Financial Highlights

revenue
$1,523.9M
total Assets
$2,001.5M
total Debt
$1,026.0M
net Income
$(438.2)M
eps
$(8.04)
gross Margin
18.0%
cash Position
$97.1M
revenue Growth
0.1%

Key Numbers

Key Players & Entities

FAQ

What caused Mativ Holdings, Inc.'s significant net loss for the nine months ended September 30, 2025?

Mativ Holdings, Inc.'s significant net loss of $438.2 million for the nine months ended September 30, 2025, was primarily driven by a substantial goodwill impairment expense of $411.9 million recognized during that period.

How did Mativ's net sales perform in the third quarter of 2025 compared to the previous year?

Mativ's net sales for the three months ended September 30, 2025, increased to $513.7 million, up from $498.5 million in the same period of 2024, representing a modest growth of $15.2 million.

What was the change in Mativ Holdings, Inc.'s operating profit for the third quarter of 2025?

Mativ Holdings, Inc. reported an operating profit of $16.0 million for the three months ended September 30, 2025, which is an improvement from the $7.0 million operating profit recorded in the third quarter of 2024.

What is the current risk level associated with Mativ Holdings, Inc. based on this 10-Q filing?

Based on the 10-Q filing, the risk level for Mativ Holdings, Inc. is high, primarily due to the $411.9 million goodwill impairment expense, which significantly impacted the company's year-to-date net loss of $438.2 million.

How did Mativ's cash flow from operations change for the nine months ended September 30, 2025?

Mativ's net cash provided by operations for the nine months ended September 30, 2025, increased to $114.5 million, up from $70.7 million in the corresponding period of 2024, indicating improved operational cash generation.

What impact did the goodwill impairment have on Mativ's total assets?

The goodwill impairment significantly reduced Mativ's total assets. Goodwill decreased from $465.6 million at December 31, 2024, to $57.3 million at September 30, 2025, contributing to a total asset reduction from $2,447.9 million to $2,001.5 million.

What are Mativ Holdings, Inc.'s two reportable segments?

Mativ Holdings, Inc. has two reportable segments: Filtration & Advanced Materials (FAM), which focuses on filtration media, advanced films, and coating solutions, and Sustainable & Adhesive Solutions (SAS), which specializes in tapes, labels, and healthcare solutions.

What was Mativ's basic net loss per share for the nine months ended September 30, 2025?

Mativ's basic net loss per share for the nine months ended September 30, 2025, was $(8.04), a substantial increase from the $(0.93) reported for the same period in 2024, reflecting the significant year-to-date net loss.

How many shares of common stock did Mativ Holdings, Inc. have outstanding as of November 3, 2025?

As of November 3, 2025, Mativ Holdings, Inc. had 54,681,114 shares of common stock outstanding.

What new accounting pronouncement will Mativ be evaluating for its impact on disclosures?

Mativ is currently evaluating ASU 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures," which requires disaggregated disclosures of certain expense categories, to determine its impact on the company's disclosures.

Risk Factors

Industry Context

Mativ Holdings operates in the filtration and engineered materials sectors. The slight increase in net sales suggests a stable but competitive market environment. Companies in this space often face pressures related to raw material costs, technological innovation, and global supply chain dynamics.

Regulatory Implications

The company's financial reporting adheres to U.S. GAAP. Significant non-cash charges like goodwill impairment require clear disclosure and can impact investor perception. Compliance with environmental and safety regulations relevant to manufacturing operations is also a continuous requirement.

What Investors Should Do

  1. Monitor the impact of the goodwill impairment on future financial performance and asset valuations.
  2. Analyze the drivers of improved operating profit in Q3 2025 and assess sustainability.
  3. Evaluate the company's cash flow generation and debt management strategies.
  4. Assess the competitive landscape and Mativ's market position in its key segments.

Key Dates

Glossary

Goodwill impairment expense
A non-cash charge recorded when the carrying value of goodwill on a company's balance sheet exceeds its fair value, indicating a permanent reduction in its value. (A significant $411.9 million goodwill impairment expense heavily impacted Mativ's net loss for the nine months ended September 30, 2025.)
Operating profit (loss)
A measure of a company's profitability from its core business operations before accounting for interest and taxes. (Mativ reported an operating profit of $16.0 million for Q3 2025, an improvement from $7.0 million in Q3 2024, but a substantial operating loss of $394.5 million for the nine months due to impairment charges.)
Net sales
The total revenue generated from the sale of goods or services after deducting returns, allowances, and discounts. (Mativ's net sales showed a slight increase for the three and nine-month periods ended September 30, 2025, compared to the prior year.)
Cash provided by operations
The amount of cash generated from a company's normal business operations. (Mativ's cash provided by operations increased to $114.5 million for the nine months ended September 30, 2025, up from $70.7 million in the prior year, indicating improved cash generation from core activities.)

Year-Over-Year Comparison

Compared to the prior year's nine-month period, Mativ Holdings reported a significantly larger net loss of $438.2 million, primarily due to a $411.9 million goodwill impairment charge, compared to a $50.2 million loss. While net sales saw a marginal increase to $1,523.9 million from $1,522.5 million, the gross profit declined. However, cash provided by operations improved substantially to $114.5 million from $70.7 million, and total assets decreased due to the goodwill write-down.

Filing Stats: 4,650 words · 19 min read · ~16 pages · Grade level 8.1 · Accepted 2025-11-06 16:52:34

Key Financial Figures

Filing Documents

- Financial Information

Part I. - Financial Information

Financial Statements

Item 1. Financial Statements 2

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 31

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 43

Controls and Procedures

Item 4. Controls and Procedures 43

- Other Information

Part II. - Other Information

Legal Proceedings

Item 1. Legal Proceedings 45

Risk Factors

Item 1A. Risk Factors 45

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 45

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 45

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 45

Other Information

Item 5. Other Information 45

Exhibits

Item 6. Exhibits 47

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements MATIV HOLDINGS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (in millions, except per share amounts) (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net sales $ 513.7 $ 498.5 $ 1,523.9 $ 1,522.5 Cost of products sold 414.3 404.9 1,248.2 1,236.0 Gross profit 99.4 93.6 275.7 286.5 Selling and general expense 53.7 54.3 174.2 181.0 Research and development expense 5.6 5.7 18.6 17.5 Intangible asset amortization expense 16.0 15.4 47.3 46.9 Total nonmanufacturing expenses 75.3 75.4 240.1 245.4 Goodwill impairment expense — — 411.9 — Restructuring and other impairment expense 8.1 11.2 18.2 37.4 Operating profit (loss) 16.0 7.0 ( 394.5 ) 3.7 Interest expense 17.7 18.3 54.1 55.0 Other expense, net ( 3.9 ) ( 12.7 ) ( 4.2 ) ( 12.1 ) Loss before income taxes ( 5.6 ) ( 24.0 ) ( 452.8 ) ( 63.4 ) Income tax benefit, net ( 2.4 ) ( 3.2 ) ( 14.6 ) ( 13.2 ) Net loss $ ( 3.2 ) $ ( 20.8 ) $ ( 438.2 ) $ ( 50.2 ) Net loss per share: Basic $ ( 0.06 ) $ ( 0.38 ) $ ( 8.04 ) $ ( 0.93 ) Diluted $ ( 0.06 ) $ ( 0.38 ) $ ( 8.04 ) $ ( 0.93 ) Weighted average shares outstanding: Basic 54,671,900 54,327,500 54,582,100 54,305,800 Diluted 54,671,900 54,327,500 54,582,100 54,305,800 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 2 MATIV HOLDINGS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (in millions) (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net loss $ ( 3.2 ) $ ( 20.8 ) $ ( 438.2 ) $ ( 50.2 ) Other comprehensive income (loss), net of tax: Foreign currency translation adjustments ( 0.7 ) 21.7 10.4 10.9 Unrealized loss on derivative instruments ( 3.3 ) ( 13.5 ) ( 15.1 ) ( 13.8 ) Net gain (loss) from postretirement benefit plans ( 8.3 ) 0.2 ( 8.2 ) 0.5 Other comprehensive income (

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing